RT Journal Article
SR Electronic
T1 New topical drugs for open-angle glaucoma
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 12
OP 14
DO 10.1136/dtb.2003.41212
VO 41
IS 2
YR 2003
UL http://dtb.bmj.com/content/41/2/12.abstract
AB Relevant BNF section: 11.6When we reviewed the management of open-angle glaucoma in 1997,1 the topical drug treatments available included beta-blockers, a carbonic anhydrase inhibitor (dorzolamide), an alpha2 agonist (apraclonidine), a prostaglandin analogue (latanoprost) and a variety of miotics and sympathomimetics. We concluded that a beta-blocker was the treatment of first choice. Here, we review seven new topical preparations that have been marketed, or had their licensed indications changed, since our earlier article.